Murakawa Tomohiro, Sato Hajime, Okumura Sakae, Nakajima Jun, Horio Hirotoshi, Ozeki Yuichi, Asamura Hisao, Ikeda Norihiko, Otsuka Hajime, Matsuguma Haruhisa, Yoshino Ichiro, Chida Masayuki, Nakayama Mitsuo, Iizasa Toshihiko, Okumura Meinoshin, Shiono Satoshi, Kato Ryoichi, Iida Tomohiko, Matsutani Noriyuki, Kawamura Masafumi, Sakao Yukinori, Funai Kazuhito, Furuyashiki Go, Akiyama Hirohiko, Sugiyama Shigeki, Kanauchi Naoki, Shiraishi Yuji
Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Department of Health Policy and Technology Assessment, National Institute of Public Health, Saitama, Japan.
Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1157-1163. doi: 10.1093/ejcts/ezx020.
Thoracoscopic surgery for lung metastasectomy remains controversial. The study aimed at determining the efficacy of thoracoscopic surgery for lung metastasectomy.
This was a multi-institutional, retrospective study that included 1047 patients who underwent lung metastasectomy for colorectal cancer between 1999 and 2014. Prognostic factors of overall survival were compared between the thoracoscopic and open thoracotomy groups using the multivariate Cox proportional hazard model. The propensity score, calculated using the preoperative covariates, included the era of lung surgery as a covariate. A stepwise backward elimination method, with a probability level of 0.15, was used to select the most powerful sets of outcome predictors. The difference between the radiological tumour number and the resected tumour number (delta_num) was also evaluated.
The c -statistics and the P -value of the Hosmer-Lemeshow Chi-square of the propensity score model were 0.7149 and 0.1579, respectively. After adjusting for the propensity score, the thoracoscopy group had a better survival rate than the open group (stratified log-rank test: P = 0.0353). After adjusting for the propensity score, the most powerful predictive model for overall survival was that which combined thoracoscopy [hazard ratio (HR): 0.468, 95% CI: 0.262-0.838, P = 0.011] and anatomical resection (HR: 1.49, 95% CI: 1.134-1.953, P = 0.004). Before adjusting for the propensity score, the delta_num was significantly greater in the open group than in the thoracoscopy group (thoracoscopy: 0.06, open: 0.33, P = 0.001); however, after adjustment, there was no difference in the delta_num (thoracoscopy: 0.04, open: 0.19, P = 0.114).
Thoracoscopic metastasectomy showed better overall survival than the open approach in this analysis. The thoracoscopic approach may be an acceptable option for resection of pulmonary metastases in terms of tumour identification and survival outcome in the current era.
胸腔镜手术用于肺转移瘤切除术仍存在争议。本研究旨在确定胸腔镜手术用于肺转移瘤切除术的疗效。
这是一项多机构回顾性研究,纳入了1999年至2014年间接受肺转移瘤切除术治疗结直肠癌的1047例患者。使用多变量Cox比例风险模型比较胸腔镜组和开胸手术组的总生存预后因素。利用术前协变量计算的倾向评分,将肺手术时代作为协变量纳入。采用逐步向后剔除法,以0.15的概率水平选择最有力的一组结局预测因素。还评估了影像学肿瘤数量与切除肿瘤数量之间的差异(delta_num)。
倾向评分模型的c统计量和Hosmer-Lemeshow卡方检验的P值分别为0.7149和0.1579。在对倾向评分进行调整后,胸腔镜组的生存率高于开胸组(分层对数秩检验:P = 0.0353)。在对倾向评分进行调整后,总生存的最有力预测模型是将胸腔镜手术[风险比(HR):0.468,95%可信区间:0.262 - 0.838,P = 0.011]和解剖性切除(HR:1.49,95%可信区间:1.134 - 1.953,P = 0.004)相结合的模型。在对倾向评分进行调整前,开胸组的delta_num显著高于胸腔镜组(胸腔镜组:0.06,开胸组:0.33,P = 0.001);然而,调整后,delta_num无差异(胸腔镜组:0.04,开胸组:0.19,P = 0.114)。
在本分析中,胸腔镜下转移瘤切除术的总生存情况优于开胸手术。就当前时代的肿瘤识别和生存结局而言,胸腔镜手术方法可能是切除肺转移瘤的一个可接受的选择。